Adma Biologics | ADMA - Ebitda

Prix De L'Action
13.59
Variation Quotidienne
-0.73 -5.10%
Mensuellement
-12.44%
Annuel
-33.12%
Q1 Prévisions
13.89




Ebitda Changement Date
Adma Biologics USD 73.59M 14.85M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Novavax USD 19.36M 190.79M 2025-12
Omeros USD -47.96M 7.39M 2023-09
Takeda JPY 448.13B 173.98B 2025-12